This is one more step towards a vaccine against the coronavirus.
The Pfizer and BioNTech laboratories announced Tuesday in a press release that they had filed a conditional authorization request with the European Medicines Agency to be able to market their vaccine in Europe.
The vaccine would be 95% effective according to these laboratories.
The Pfizer / BioNTech alliance announced on Tuesday that it had filed the application for conditional authorization of its Covid-19 vaccine in the EU with the European Medicines Agency (EMA), saying it hoped for its distribution by the end of the month.
95% efficient
>>
LIVE
- Coronavirus: follow the evolution of the situation Tuesday, December 1
The "formal request" to the EMA was filed on Monday, German laboratory BioNTech, which is associated with US giant Pfizer, said in a statement, after large-scale test results showed 95% effectiveness of their vaccine.